{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T09:02:58Z","timestamp":1776502978283,"version":"3.51.2"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Manipal Academy of Higher Education, Dubai"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The progression of Parkinson\u2019s disease (PD) is influenced by genetic factors, particularly the Synuclein-Alpha (<jats:italic>SNCA<\/jats:italic>) gene, which encodes the alpha-synuclein (\u03b1-syn) protein involved in dopaminergic neuron degeneration. This study aimed to explore the relationship between rs356220 and PD risk and to understand its functional impact through computational analysis. We thoroughly reviewed nine databases regarding the association between this variant and PD risk. Firstly, a meta-analysis of 9 articles, consisting of 10 studies with 11,638 cases and 37,393 controls was conducted, that identified the C allele of rs356220 as a protective factor against PD (Odds Ratio (OR) 0.91, 95% Confidence Interval (CI): 0.88\u20130.94, P\u2009=\u20093.82E\u221208)). Subsequently, we characterized the functional impact of this non-coding variant in the pathophysiology of PD. In-silico process flow included transcription factor binding site (TFBS) analysis, pathway enrichment analysis, and protein interaction analysis. The TFBS analysis suggested that the C allele may influence multiple factors, while subsequent Pathway and Protein Network analyses identified proteins that enhance SNCA expression. Our investigation therefore reveals that rs356220 influences the dynamics of the \u03b1-syn protein through interactions with BAD, CANX, SLC18A1, and IRF1, potentially advancing the progression of PD. This research emphasizes the need for holistic study approaches to explore the intricacies of complex disorders like PD.<\/jats:p>","DOI":"10.1038\/s41598-025-04435-0","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:46:54Z","timestamp":1751431614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Meta-analysis and in-silico functional characterization of the SNCA variant rs356220 in Parkinson\u2019s disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Shradha","family":"Menon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3887-0592","authenticated-orcid":false,"given":"Naushad","family":"Rais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"issue":"1","key":"4435_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/MDS.10010","volume":"17","author":"L Findley","year":"2002","unstructured":"Findley, L. et al. Factors impacting on quality of life in Parkinson\u2019s disease: Results from an international survey. Mov. Disord. 17(1), 60\u201367. https:\/\/doi.org\/10.1002\/MDS.10010 (2002).","journal-title":"Mov. Disord."},{"issue":"12","key":"4435_CR2","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio, A. & Schwarzschild, M. A. The epidemiology of Parkinson\u2019s disease: Risk factors and prevention. Lancet Neurol. 15(12), 1257\u20131272. https:\/\/doi.org\/10.1016\/S1474-4422(16)30230-7 (2016).","journal-title":"Lancet Neurol."},{"issue":"1","key":"4435_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/J.NEUROL.2015.09.012","volume":"172","author":"A Elbaz","year":"2016","unstructured":"Elbaz, A., Carcaillon, L., Kab, S. & Moisan, F. Epidemiology of Parkinson\u2019s disease. Rev. Neurol. 172(1), 14\u201326. https:\/\/doi.org\/10.1016\/J.NEUROL.2015.09.012 (2016).","journal-title":"Rev. Neurol."},{"issue":"4","key":"4435_CR4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000445751","volume":"46","author":"L Hirsch","year":"2016","unstructured":"Hirsch, L., Jette, N., Frolkis, A., Steeves, T. & Pringsheim, T. The incidence of Parkinson\u2019s disease: A systematic review and meta-analysis. Neuroepidemiology 46(4), 292\u2013300. https:\/\/doi.org\/10.1159\/000445751 (2016).","journal-title":"Neuroepidemiology"},{"issue":"2","key":"4435_CR5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/J.MCNA.2018.10.014","volume":"103","author":"SG Reich","year":"2019","unstructured":"Reich, S. G. & Savitt, J. M. Parkinson\u2019s disease. Med. Clin. North Am. 103(2), 337\u2013350. https:\/\/doi.org\/10.1016\/J.MCNA.2018.10.014 (2019).","journal-title":"Med. Clin. North Am."},{"issue":"1","key":"4435_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S00221-023-06735-1","volume":"242","author":"K Chandrababu","year":"2023","unstructured":"Chandrababu, K. et al. Unravelling the Parkinson\u2019s puzzle, from medications and surgery to stem cells and genes: A comprehensive review of current and future management strategies. Exp. Brain Res. 242(1), 1\u201323. https:\/\/doi.org\/10.1007\/S00221-023-06735-1 (2023).","journal-title":"Exp. Brain Res."},{"issue":"7","key":"4435_CR7","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/ENE.13624","volume":"25","author":"A Antonini","year":"2018","unstructured":"Antonini, A. et al. Pain in Parkinson\u2019s disease: Facts and uncertainties. Eur. J. Neurol. 25(7), 917-e69. https:\/\/doi.org\/10.1111\/ENE.13624 (2018).","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"4435_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ENE.14108","volume":"27","author":"R Balestrino","year":"2020","unstructured":"Balestrino, R. & Schapira, A. H. V. Parkinson disease. Eur. J. Neurol. 27(1), 27\u201342. https:\/\/doi.org\/10.1111\/ENE.14108 (2020).","journal-title":"Eur. J. Neurol."},{"issue":"11","key":"4435_CR9","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/ENE.13398","volume":"24","author":"TH Mertsalmi","year":"2017","unstructured":"Mertsalmi, T. H. et al. More than constipation\u2014bowel symptoms in Parkinson\u2019s disease and their connection to gut microbiota. Eur. J. Neurol. 24(11), 1375\u20131383. https:\/\/doi.org\/10.1111\/ENE.13398 (2017).","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"4435_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/JAMANEUROL.2017.3299","volume":"75","author":"ER Dorsey","year":"2018","unstructured":"Dorsey, E. R. & Bloem, B. R. The Parkinson pandemic\u2014A call to action. JAMA Neurol. 75(1), 9\u201310. https:\/\/doi.org\/10.1001\/JAMANEUROL.2017.3299 (2018).","journal-title":"JAMA Neurol."},{"issue":"10009","key":"4435_CR11","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/S0140-6736(15)61340-X","volume":"386","author":"CJL Murray","year":"2015","unstructured":"Murray, C. J. L. et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990\u20132013: Quantifying the epidemiological transition. Lancet 386(10009), 2145. https:\/\/doi.org\/10.1016\/S0140-6736(15)61340-X (2015).","journal-title":"Lancet"},{"issue":"11","key":"4435_CR12","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1007\/S00415-019-09382-1\/FIGURES\/1","volume":"267","author":"C Raccagni","year":"2020","unstructured":"Raccagni, C. et al. Gait and postural disorders in parkinsonism: A clinical approach. J. Neurol. 267(11), 3169\u20133176. https:\/\/doi.org\/10.1007\/S00415-019-09382-1\/FIGURES\/1 (2020).","journal-title":"J. Neurol."},{"issue":"1","key":"4435_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/J.BRAINRESREV.2004.04.007","volume":"46","author":"Y Huang","year":"2004","unstructured":"Huang, Y., Cheung, L., Rowe, D. & Halliday, G. Genetic contributions to Parkinson\u2019s disease. Brain Res. Rev. 46(1), 44\u201370. https:\/\/doi.org\/10.1016\/J.BRAINRESREV.2004.04.007 (2004).","journal-title":"Brain Res. Rev."},{"issue":"12","key":"4435_CR14","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-genome wide association study. Lancet Neurol. 18(12), 1091. https:\/\/doi.org\/10.1016\/S1474-4422(19)30320-5 (2019).","journal-title":"Lancet Neurol."},{"issue":"1","key":"4435_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","volume":"14","author":"HA Lashuel","year":"2012","unstructured":"Lashuel, H. A., Overk, C. R., Oueslati, A. & Masliah, E. The many faces of \u03b1-synuclein: from structure and toxicity to therapeutic target. Nat. Rev. Neurosci. 14(1), 38\u201348. https:\/\/doi.org\/10.1038\/nrn3406 (2012).","journal-title":"Nat. Rev. Neurosci."},{"issue":"6","key":"4435_CR16","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/J.NEURON.2013.09.004","volume":"79","author":"JT Bendor","year":"2013","unstructured":"Bendor, J. T., Logan, T. P. & Edwards, R. H. The function of \u03b1-synuclein. Neuron 79(6), 1044\u20131066. https:\/\/doi.org\/10.1016\/J.NEURON.2013.09.004 (2013).","journal-title":"Neuron"},{"issue":"6","key":"4435_CR17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/S00109-013-1038-9","volume":"91","author":"SE Eisbach","year":"2013","unstructured":"Eisbach, S. E., Outeiro, T. F., Eisbach, S. E. & Outeiro, T. F. alpha-Synuclein and intracellular trafficking: impact on the spreading of Parkinson\u2019s disease pathology. J. Mol. Med. 91(6), 693\u2013703. https:\/\/doi.org\/10.1007\/S00109-013-1038-9 (2013).","journal-title":"J. Mol. Med."},{"issue":"1","key":"4435_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/J.ARR.2014.04.002","volume":"15","author":"H Deng","year":"2014","unstructured":"Deng, H. & Yuan, L. Genetic variants and animal models in SNCA and Parkinson disease. Ageing Res. Rev. 15(1), 161\u2013176. https:\/\/doi.org\/10.1016\/J.ARR.2014.04.002 (2014).","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"4435_CR19","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3233\/JPD-150642","volume":"5","author":"J Burr\u00e9","year":"2015","unstructured":"Burr\u00e9, J. The synaptic function of \u03b1-synuclein. J. Parkinsons Dis. 5(4), 699. https:\/\/doi.org\/10.3233\/JPD-150642 (2015).","journal-title":"J. Parkinsons Dis."},{"key":"4435_CR20","doi-asserted-by":"publisher","DOI":"10.1101\/CSHPERSPECT.A024091","author":"J Burr\u00e9","year":"2018","unstructured":"Burr\u00e9, J., Sharma, M. & S\u00fcdhof, T. C. Cell biology and pathophysiology of \u03b1-synuclein. Cold Spring Harb Perspect. Med. https:\/\/doi.org\/10.1101\/CSHPERSPECT.A024091 (2018).","journal-title":"Cold Spring Harb Perspect. Med."},{"issue":"D1","key":"4435_CR21","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/NAR\/GKAC963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51(D1), D587\u2013D592. https:\/\/doi.org\/10.1093\/NAR\/GKAC963 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"4435_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/NAR\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27\u201330. https:\/\/doi.org\/10.1093\/NAR\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"4435_CR23","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/PRO.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28(11), 1947\u20131951. https:\/\/doi.org\/10.1002\/PRO.3715 (2019).","journal-title":"Protein Sci."},{"issue":"2","key":"4435_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/BIOLOGY8020038","volume":"8","author":"C Chen","year":"2019","unstructured":"Chen, C., Turnbull, D. M. & Reeve, A. K. Mitochondrial dysfunction in Parkinson\u2019s disease\u2014cause or consequence?. Biology 8(2), 38. https:\/\/doi.org\/10.3390\/BIOLOGY8020038 (2019).","journal-title":"Biology"},{"key":"4435_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2021.794580\/BIBTEX","volume":"12","author":"M Shi","year":"2022","unstructured":"Shi, M., Chai, Y., Zhang, J. & Chen, X. Endoplasmic reticulum stress-associated neuronal death and innate immune response in neurological diseases. Front. Immunol. 12, 794580. https:\/\/doi.org\/10.3389\/FIMMU.2021.794580\/BIBTEX (2022).","journal-title":"Front. Immunol."},{"issue":"5","key":"4435_CR26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/S13205-023-03553-8","volume":"13","author":"H Adam","year":"2023","unstructured":"Adam, H. et al. An update on pathogenesis and clinical scenario for Parkinson\u2019s disease: Diagnosis and treatment. 3 Biotech. 13(5), 142. https:\/\/doi.org\/10.1007\/S13205-023-03553-8 (2023).","journal-title":"3 Biotech."},{"key":"4435_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/J.SEMCDB.2021.08.008","volume":"121","author":"T Fadason","year":"2022","unstructured":"Fadason, T. et al. Assigning function to SNPs: Considerations when interpreting genetic variation. Semin. Cell Dev. Biol. 121, 135\u2013142. https:\/\/doi.org\/10.1016\/J.SEMCDB.2021.08.008 (2022).","journal-title":"Semin. Cell Dev. Biol."},{"issue":"11","key":"4435_CR28","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1001\/ARCHNEUROL.2010.279","volume":"67","author":"IF Mata","year":"2010","unstructured":"Mata, I. F. et al. SNCA variant associated with Parkinson disease and plasma \u03b1-synuclein level. Arch. Neurol. 67(11), 1350\u20131356. https:\/\/doi.org\/10.1001\/ARCHNEUROL.2010.279 (2010).","journal-title":"Arch. Neurol."},{"issue":"2","key":"4435_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/J.1469-1809.2009.00560.X","volume":"74","author":"TL Edwards","year":"2010","unstructured":"Edwards, T. L. et al. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann. Hum. Genet. 74(2), 97\u2013109. https:\/\/doi.org\/10.1111\/J.1469-1809.2009.00560.X (2010).","journal-title":"Ann. Hum. Genet."},{"key":"4435_CR30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1471-2377-12-62","volume":"12","author":"Y Miyake","year":"2012","unstructured":"Miyake, Y. et al. UCHL1 S18Y variant is a risk factor for Parkinson\u2019s disease in Japan. BMC Neurol. 12, 62. https:\/\/doi.org\/10.1186\/1471-2377-12-62 (2012).","journal-title":"BMC Neurol."},{"issue":"12","key":"4435_CR31","doi-asserted-by":"publisher","first-page":"2882.e1","DOI":"10.1016\/J.NEUROBIOLAGING.2014.07.014","volume":"35","author":"XY Guo","year":"2014","unstructured":"Guo, X. Y. et al. SNCA variants rs2736990 and rs356220 as risk factors for Parkinson\u2019s disease but not for amyotrophic lateral sclerosis and multiple system atrophy in a Chinese population. Neurobiol. Aging 35(12), 2882.e1-2882.e6. https:\/\/doi.org\/10.1016\/J.NEUROBIOLAGING.2014.07.014 (2014).","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"4435_CR32","doi-asserted-by":"publisher","first-page":"360","DOI":"10.4103\/0028-3886.117595","volume":"61","author":"F Pan","year":"2013","unstructured":"Pan, F. et al. Association of polymorphism in rs2736990 of the \u03b1-synuclein gene with Parkinson\u2019s disease in a Chinese population. Neurol. India 61(4), 360. https:\/\/doi.org\/10.4103\/0028-3886.117595 (2013).","journal-title":"Neurol. India"},{"issue":"5","key":"4435_CR33","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/S10072-015-2420-X\/TABLES\/4","volume":"37","author":"N Shahmohammadibeni","year":"2016","unstructured":"Shahmohammadibeni, N. et al. The analysis of association between SNCA, HUSEYO and CSMD1 gene variants and Parkinson\u2019s disease in Iranian population. Neurol. Sci. 37(5), 731\u2013736. https:\/\/doi.org\/10.1007\/S10072-015-2420-X\/TABLES\/4 (2016).","journal-title":"Neurol. Sci."},{"issue":"3","key":"4435_CR34","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/J.TIG.2021.08.010\/ASSET\/673E5FEF-1CE3-44AA-B70B-23B1851BB05A\/MAIN.ASSETS\/GR2.JPG","volume":"38","author":"A Frydas","year":"2022","unstructured":"Frydas, A., Wauters, E., van der Zee, J. & Van Broeckhoven, C. Uncovering the impact of noncoding variants in neurodegenerative brain diseases. Trends Genet. 38(3), 258\u2013272. https:\/\/doi.org\/10.1016\/J.TIG.2021.08.010\/ASSET\/673E5FEF-1CE3-44AA-B70B-23B1851BB05A\/MAIN.ASSETS\/GR2.JPG (2022).","journal-title":"Trends Genet."},{"issue":"2","key":"4435_CR35","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X\/ASSET\/DDBBD248-3B4D-4B11-8803-64B36A041C23\/MAIN.ASSETS\/GR2.JPG","volume":"19","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat, C., Nalls, M. A. & Singleton, A. B. The genetic architecture of Parkinson\u2019s disease. Lancet Neurol. 19(2), 170\u2013178. https:\/\/doi.org\/10.1016\/S1474-4422(19)30287-X\/ASSET\/DDBBD248-3B4D-4B11-8803-64B36A041C23\/MAIN.ASSETS\/GR2.JPG (2020).","journal-title":"Lancet Neurol."},{"issue":"1","key":"4435_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-024-00659-5","volume":"10","author":"SL Farrow","year":"2024","unstructured":"Farrow, S. L. et al. Identification of 27 allele-specific regulatory variants in Parkinson\u2019s disease using a massively parallel reporter assay. npj Parkinson\u2019s Dis. 10(1), 1\u201314. https:\/\/doi.org\/10.1038\/s41531-024-00659-5 (2024).","journal-title":"npj Parkinson\u2019s Dis."},{"issue":"4","key":"4435_CR37","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/ANA.20438","volume":"57","author":"JC Mueller","year":"2005","unstructured":"Mueller, J. C. et al. Multiple regions of \u03b1-synuclein are associated with Parkinson\u2019s disease. Ann. Neurol. 57(4), 535\u2013541. https:\/\/doi.org\/10.1002\/ANA.20438 (2005).","journal-title":"Ann. Neurol."},{"issue":"8","key":"4435_CR38","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/MDS.22524","volume":"24","author":"N Pankratz","year":"2009","unstructured":"Pankratz, N. et al. Alpha-synuclein and familial Parkinson\u2019s disease. Mov. Disord. 24(8), 1125. https:\/\/doi.org\/10.1002\/MDS.22524 (2009).","journal-title":"Mov. Disord."},{"issue":"8","key":"4435_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PGEN.1002237","volume":"7","author":"TH Hamza","year":"2011","unstructured":"Hamza, T. H. et al. Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson\u2019s disease modifier gene via interaction with coffee. PLoS Genet. 7(8), e1002237. https:\/\/doi.org\/10.1371\/JOURNAL.PGEN.1002237 (2011).","journal-title":"PLoS Genet."},{"issue":"6","key":"4435_CR40","doi-asserted-by":"publisher","first-page":"1002141","DOI":"10.1371\/JOURNAL.PGEN.1002141","volume":"7","author":"CB Do","year":"2011","unstructured":"Do, C. B. et al. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson\u2019s disease. PLoS Genet. 7(6), 1002141. https:\/\/doi.org\/10.1371\/JOURNAL.PGEN.1002141 (2011).","journal-title":"PLoS Genet."},{"issue":"3\u20133","key":"4435_CR41","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/J.PARKRELDIS.2011.10.014","volume":"18\u2013135","author":"L Trotta","year":"2012","unstructured":"Trotta, L. et al. SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population. Parkinsonism Relat. Disord. 18\u2013135(3\u20133), 257. https:\/\/doi.org\/10.1016\/J.PARKRELDIS.2011.10.014 (2012).","journal-title":"Parkinsonism Relat. Disord."},{"issue":"5","key":"4435_CR42","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.parkreldis.2012.02.016","volume":"18","author":"Y Miyake","year":"2012","unstructured":"Miyake, Y. et al. SNCA polymorphisms, smoking, and sporadic Parkinson\u2019s disease in Japanese. Parkinsonism Relat. Disord. 18(5), 557\u2013561. https:\/\/doi.org\/10.1016\/j.parkreldis.2012.02.016 (2012).","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"4435_CR43","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1471-2164-15-118","volume":"15","author":"EM Hill-Burns","year":"2014","unstructured":"Hill-Burns, E. M. et al. Identification of a novel Parkinson\u2019s disease locus via stratified genome-wide association study. BMC Genomics 15(1), 118. https:\/\/doi.org\/10.1186\/1471-2164-15-118 (2014).","journal-title":"BMC Genomics"},{"key":"4435_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/S12859-017-1990-4","author":"J Martorell-Marugan","year":"2017","unstructured":"Martorell-Marugan, J., Toro-Dominguez, D., Alarcon-Riquelme, M. E. & Carmona-Saez, P. MetaGenyo: A web tool for meta-analysis of genetic association studies. BMC Bioinform. https:\/\/doi.org\/10.1186\/S12859-017-1990-4 (2017).","journal-title":"BMC Bioinform."},{"issue":"9","key":"4435_CR45","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.tig.2004.06.014","volume":"20","author":"MR Munaf\u00f2","year":"2004","unstructured":"Munaf\u00f2, M. R. & Flint, J. Meta-analysis of genetic association studies. Trends Genet. 20(9), 439\u2013444. https:\/\/doi.org\/10.1016\/j.tig.2004.06.014 (2004).","journal-title":"Trends Genet."},{"key":"4435_CR46","doi-asserted-by":"publisher","unstructured":"Higgins, J. P. & Green, S. Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series, 1\u2013649 https:\/\/doi.org\/10.1002\/9780470712184 (2008).","DOI":"10.1002\/9780470712184"},{"issue":"4","key":"4435_CR47","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0895-4356(03)00011-8","volume":"56","author":"J Attia","year":"2003","unstructured":"Attia, J., Thakkinstian, A. & D\u2019Este, C. Meta-analyses of molecular association studies: Methodologic lessons for genetic epidemiology. J. Clin. Epidemiol. 56(4), 297\u2013303. https:\/\/doi.org\/10.1016\/S0895-4356(03)00011-8 (2003).","journal-title":"J. Clin. Epidemiol."},{"issue":"7109","key":"4435_CR48","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/BMJ.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger, M., Smith, G. D., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ Br. Med. J. 315(7109), 629. https:\/\/doi.org\/10.1136\/BMJ.315.7109.629 (1997).","journal-title":"BMJ Br. Med. J."},{"issue":"W1","key":"4435_CR49","doi-asserted-by":"publisher","first-page":"W322","DOI":"10.1093\/NAR\/GKAC393","volume":"50","author":"R Steinhaus","year":"2022","unstructured":"Steinhaus, R., Robinson, P. N. & Seelow, D. FABIAN-variant: Predicting the effects of DNA variants on transcription factor binding. Nucleic Acids Res. 50(W1), W322. https:\/\/doi.org\/10.1093\/NAR\/GKAC393 (2022).","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"4435_CR50","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1101\/GR.137323.112","volume":"22","author":"AP Boyle","year":"2012","unstructured":"Boyle, A. P. et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 22(9), 1790. https:\/\/doi.org\/10.1101\/GR.137323.112 (2012).","journal-title":"Genome Res."},{"issue":"D1","key":"4435_CR51","doi-asserted-by":"publisher","first-page":"D930","DOI":"10.1093\/NAR\/GKR917","volume":"40","author":"LD Ward","year":"2012","unstructured":"Ward, L. D. & Kellis, M. HaploReg: A resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 40(D1), D930\u2013D934. https:\/\/doi.org\/10.1093\/NAR\/GKR917 (2012).","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"4435_CR52","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/J.CMET.2022.03.011","volume":"34","author":"P Dornbos","year":"2022","unstructured":"Dornbos, P. et al. Evaluating human genetic support for hypothesized metabolic disease genes. Cell Metab. 34(5), 661. https:\/\/doi.org\/10.1016\/J.CMET.2022.03.011 (2022).","journal-title":"Cell Metab."},{"key":"4435_CR53","doi-asserted-by":"publisher","DOI":"10.1101\/2022.10.18.512627","author":"S Dong","year":"2022","unstructured":"Dong, S. et al. Annotating and prioritizing human non-coding variants with RegulomeDB. bioRxiv https:\/\/doi.org\/10.1101\/2022.10.18.512627 (2022).","journal-title":"bioRxiv"},{"issue":"Database issue","key":"4435_CR54","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/NAR\/GKX1013","volume":"46","author":"H Han","year":"2018","unstructured":"Han, H. et al. TRRUST v2: An expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res. 46(Database issue), D380. https:\/\/doi.org\/10.1093\/NAR\/GKX1013 (2018).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"4435_CR55","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/GR.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13(11), 2498. https:\/\/doi.org\/10.1101\/GR.1239303 (2003).","journal-title":"Genome Res."},{"issue":"Database issue","key":"4435_CR56","doi-asserted-by":"publisher","first-page":"D685","DOI":"10.1093\/NAR\/GKQ1039","volume":"39","author":"EG Cerami","year":"2011","unstructured":"Cerami, E. G. et al. Pathway Commons, a web resource for biological pathway data. Nucleic Acids Res. 39(Database issue), D685. https:\/\/doi.org\/10.1093\/NAR\/GKQ1039 (2011).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"4435_CR57","doi-asserted-by":"publisher","first-page":"D489","DOI":"10.1093\/NAR\/GKZ946","volume":"48","author":"I Rodchenkov","year":"2020","unstructured":"Rodchenkov, I. et al. Pathway commons 2019 update: Integration, analysis and exploration of pathway data. Nucleic Acids Res 48(D1), D489\u2013D497. https:\/\/doi.org\/10.1093\/NAR\/GKZ946 (2020).","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"4435_CR58","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/NAR\/GKAC1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: Protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51(D1), D638. https:\/\/doi.org\/10.1093\/NAR\/GKAC1000 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"4435_CR59","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/J.BBADIS.2008.11.008","volume":"1792","author":"JM Bras","year":"2009","unstructured":"Bras, J. M. & Singleton, A. Genetic susceptibility in Parkinson\u2019s disease. Biochim. Biophys. Acta 1792(7), 597. https:\/\/doi.org\/10.1016\/J.BBADIS.2008.11.008 (2009).","journal-title":"Biochim. Biophys. Acta"},{"issue":"5646","key":"4435_CR60","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/SCIENCE.1090278\/SUPPL_FILE\/SINGLETON.SOM.PDF","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton, A. B. et al. \u03b1-synuclein locus triplication causes Parkinson\u2019s disease. Science (1979) 302(5646), 841. https:\/\/doi.org\/10.1126\/SCIENCE.1090278\/SUPPL_FILE\/SINGLETON.SOM.PDF (2003).","journal-title":"Science (1979)"},{"issue":"10","key":"4435_CR61","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1212\/01.WNL.0000127517.33208.F4","volume":"62","author":"DW Miller","year":"2004","unstructured":"Miller, D. W. et al. \u03b1-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology 62(10), 1835\u20131838. https:\/\/doi.org\/10.1212\/01.WNL.0000127517.33208.F4 (2004).","journal-title":"Neurology"},{"issue":"7","key":"4435_CR62","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/HMG\/DDL030","volume":"15","author":"I Mizuta","year":"2006","unstructured":"Mizuta, I. et al. Multiple candidate gene analysis identifies \u03b1-synuclein as a susceptibility gene for sporadic Parkinson\u2019s disease. Hum. Mol. Genet. 15(7), 1151\u20131158. https:\/\/doi.org\/10.1093\/HMG\/DDL030 (2006).","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"4435_CR63","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/J.1600-0404.2008.01019.X","volume":"118","author":"R Myhre","year":"2008","unstructured":"Myhre, R. et al. Multiple alpha-synuclein gene polymorphisms are associated with Parkinson\u2019s disease in a Norwegian population. Acta Neurol. Scand. 118(5), 320\u2013327. https:\/\/doi.org\/10.1111\/J.1600-0404.2008.01019.X (2008).","journal-title":"Acta Neurol. Scand."},{"issue":"12","key":"4435_CR64","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.3390\/BIOM11121799","volume":"11","author":"A Bla\u017eekovi\u0107","year":"2021","unstructured":"Bla\u017eekovi\u0107, A., Jer\u010di\u0107, K. G., Borove\u010dki, F., Deurwaerd\u00e8re, D. & Parnetti, L. SNCA 3\u2032 UTR genetic variants in patients with Parkinson\u2019s disease. Biomolecules 11(12), 1799. https:\/\/doi.org\/10.3390\/BIOM11121799 (2021).","journal-title":"Biomolecules"},{"issue":"7571","key":"4435_CR65","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/NATURE15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Auton, A. et al. A global reference for human genetic variation. Nature 526(7571), 68. https:\/\/doi.org\/10.1038\/NATURE15393 (2015).","journal-title":"Nature"},{"issue":"7414","key":"4435_CR66","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"I Dunham","year":"2012","unstructured":"Dunham, I. et al. An integrated encyclopedia of DNA elements in the human genome. Nature 489(7414), 57\u201374. https:\/\/doi.org\/10.1038\/nature11247 (2012).","journal-title":"Nature"},{"issue":"3","key":"4435_CR67","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2217\/PGS.10.6","volume":"11","author":"KR Bailey","year":"2010","unstructured":"Bailey, K. R. & Cheng, C. Conference scene: The great debate: Genome-wide association studies in pharmacogenetics research, good or bad?. Pharmacogenomics 11(3), 305\u2013308. https:\/\/doi.org\/10.2217\/PGS.10.6 (2010).","journal-title":"Pharmacogenomics"},{"issue":"4","key":"4435_CR68","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000103512","volume":"64","author":"JPA Ioannidis","year":"2007","unstructured":"Ioannidis, J. P. A. Non-replication and inconsistency in the genome-wide association setting. Hum. Hered. 64(4), 203\u2013213. https:\/\/doi.org\/10.1159\/000103512 (2007).","journal-title":"Hum. Hered."},{"key":"4435_CR69","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/J.NBD.2018.02.007","volume":"114","author":"SE Pierce","year":"2018","unstructured":"Pierce, S. E., Tyson, T., Booms, A., Prahl, J. & Coetzee, G. A. Parkinson\u2019s disease genetic risk in a midbrain neuronal cell line. Neurobiol. Dis. 114, 53\u201364. https:\/\/doi.org\/10.1016\/J.NBD.2018.02.007 (2018).","journal-title":"Neurobiol. Dis."},{"key":"4435_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/J.NEULET.2019.134703","volume":"717","author":"M Bi","year":"2020","unstructured":"Bi, M., Kang, S., Du, X., Jiao, Q. & Jiang, H. Association between SNCA rs356220 polymorphism and Parkinson\u2019s disease: A meta-analysis. Neurosci. Lett. 717, 134703. https:\/\/doi.org\/10.1016\/J.NEULET.2019.134703 (2020).","journal-title":"Neurosci. Lett."},{"issue":"8","key":"4435_CR71","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3314","volume":"47","author":"MR Nelson","year":"2015","unstructured":"Nelson, M. R. et al. The support of human genetic evidence for approved drug indications. Nat. Genet. 47(8), 856\u2013860. https:\/\/doi.org\/10.1038\/ng.3314 (2015).","journal-title":"Nat. Genet."},{"issue":"4","key":"4435_CR72","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1001\/JAMANEUROL.2013.6222","volume":"71","author":"JM Shulman","year":"2014","unstructured":"Shulman, J. M. et al. Association of Parkinson disease risk loci with mild parkinsonian signs in older persons. JAMA Neurol. 71(4), 429\u2013435. https:\/\/doi.org\/10.1001\/JAMANEUROL.2013.6222 (2014).","journal-title":"JAMA Neurol."},{"key":"4435_CR73","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-1-60761-700-6_9\/TABLES\/3","volume":"637","author":"FW Lohoff","year":"2010","unstructured":"Lohoff, F. W. Genetic variants in the vesicular monoamine transporter 1 (VMAT1\/SLC18A1) and neuropsychiatric disorders. Methods Mol. Biol. 637, 165\u2013180. https:\/\/doi.org\/10.1007\/978-1-60761-700-6_9\/TABLES\/3 (2010).","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"4435_CR74","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1474-4422(21)00330-6","volume":"21","author":"D Weintraub","year":"2022","unstructured":"Weintraub, D. et al. The neuropsychiatry of Parkinson\u2019s disease: Advances and challenges. Lancet Neurol. 21(1), 89\u2013102. https:\/\/doi.org\/10.1016\/S1474-4422(21)00330-6 (2022).","journal-title":"Lancet Neurol."},{"issue":"14","key":"4435_CR75","doi-asserted-by":"publisher","first-page":"5782","DOI":"10.1523\/JNEUROSCI.19-14-05782.1999","volume":"19","author":"N Ostrerova","year":"1999","unstructured":"Ostrerova, N. et al. \u03b1-Synuclein shares physical and functional homology with 14\u20133-3 proteins. J. Neurosci. 19(14), 5782. https:\/\/doi.org\/10.1523\/JNEUROSCI.19-14-05782.1999 (1999).","journal-title":"J. Neurosci."},{"issue":"6","key":"4435_CR76","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3390\/BRAINSCI14060554","volume":"14","author":"N Singh","year":"2024","unstructured":"Singh, N. et al. Protein kinase C (PKC) in neurological health: Implications for Alzheimer\u2019s disease and chronic alcohol consumption. Brain Sci. 14(6), 554. https:\/\/doi.org\/10.3390\/BRAINSCI14060554 (2024).","journal-title":"Brain Sci."},{"key":"4435_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/J.BRAINRESBULL.2023.110672","volume":"199","author":"C Dai","year":"2023","unstructured":"Dai, C. et al. Glucose metabolism impairment in Parkinson\u2019s disease. Brain Res. Bull. 199, 110672. https:\/\/doi.org\/10.1016\/J.BRAINRESBULL.2023.110672 (2023).","journal-title":"Brain Res. Bull."},{"issue":"2","key":"4435_CR78","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0092-8674(00)80405-5","volume":"91","author":"SR Datta","year":"1997","unstructured":"Datta, S. R. et al. Akt phosphorylation of BAD couples survival signals to the cell- intrinsic death machinery. Cell 91(2), 231\u2013241. https:\/\/doi.org\/10.1016\/S0092-8674(00)80405-5 (1997).","journal-title":"Cell"},{"issue":"7","key":"4435_CR79","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1038\/s41418-021-00814-y","volume":"28","author":"D Moujalled","year":"2021","unstructured":"Moujalled, D., Strasser, A. & Liddell, J. R. Molecular mechanisms of cell death in neurological diseases. Cell Death Differ. 28(7), 2029\u20132044. https:\/\/doi.org\/10.1038\/s41418-021-00814-y (2021).","journal-title":"Cell Death Differ."},{"key":"4435_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/J.ISCI.2021.102942","author":"L Zhang","year":"2021","unstructured":"Zhang, L. et al. BAD-mediated neuronal apoptosis and neuroinflammation contribute to Alzheimer\u2019s disease pathology. iScience https:\/\/doi.org\/10.1016\/J.ISCI.2021.102942 (2021).","journal-title":"iScience"},{"key":"4435_CR81","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/J.TRCI.2018.03.009","volume":"4","author":"J Cummings","year":"2018","unstructured":"Cummings, J., Lee, G., Ritter, A. & Zhong, K. Alzheimer\u2019s disease drug development pipeline: 2018. Alzheimer\u2019s Dementia Transl. Res. Clin. Interv. 4, 195. https:\/\/doi.org\/10.1016\/J.TRCI.2018.03.009 (2018).","journal-title":"Alzheimer\u2019s Dementia Transl. Res. Clin. Interv."},{"issue":"3","key":"4435_CR82","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/J.NEURON.2021.10.032","volume":"110","author":"I Stojkovska","year":"2022","unstructured":"Stojkovska, I. et al. Rescue of \u03b1-synuclein aggregation in Parkinson\u2019s patient neurons by synergistic enhancement of ER proteostasis and protein trafficking. Neuron 110(3), 436-451.e11. https:\/\/doi.org\/10.1016\/J.NEURON.2021.10.032 (2022).","journal-title":"Neuron"},{"issue":"5","key":"4435_CR83","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/J.NEURON.2019.09.001","volume":"104","author":"LK Cuddy","year":"2019","unstructured":"Cuddy, L. K. et al. Stress-induced cellular clearance is mediated by the SNARE protein ykt6 and disrupted by \u03b1-synuclein. Neuron 104(5), 869-884.e11. https:\/\/doi.org\/10.1016\/J.NEURON.2019.09.001 (2019).","journal-title":"Neuron"},{"issue":"1","key":"4435_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-8-140\/FIGURES\/6","volume":"8","author":"G Maor","year":"2013","unstructured":"Maor, G. et al. Unfolded protein response in Gaucher disease: From human to Drosophila. Orphanet. J. Rare Dis. 8(1), 1\u201314. https:\/\/doi.org\/10.1186\/1750-1172-8-140\/FIGURES\/6 (2013).","journal-title":"Orphanet. J. Rare Dis."},{"issue":"6357","key":"4435_CR85","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/SCIENCE.AAM9080\/SUPPL_FILE\/AAM9080_BURBULLA_SM.PDF","volume":"357","author":"LF Burbulla","year":"2017","unstructured":"Burbulla, L. F. et al. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease. Science (1979) 357(6357), 1255\u20131261. https:\/\/doi.org\/10.1126\/SCIENCE.AAM9080\/SUPPL_FILE\/AAM9080_BURBULLA_SM.PDF (2017).","journal-title":"Science (1979)"},{"issue":"1","key":"4435_CR86","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/S40478-019-0716-4","volume":"7","author":"JH Lee","year":"2019","unstructured":"Lee, J. H. et al. Parkinson\u2019s disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes. Acta Neuropathol. Commun. 7(1), 68. https:\/\/doi.org\/10.1186\/S40478-019-0716-4 (2019).","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"4435_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-018-0039-4","volume":"4","author":"WT Chiu","year":"2018","unstructured":"Chiu, W. T. et al. Bcl-2 regulates store-operated Ca2+ entry to modulate ER stress-induced apoptosis. Cell Death Discov. 4(1), 1\u201314. https:\/\/doi.org\/10.1038\/s41420-018-0039-4 (2018).","journal-title":"Cell Death Discov."},{"issue":"16","key":"4435_CR88","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/JNCI\/DJT184","volume":"105","author":"P Leone","year":"2013","unstructured":"Leone, P. et al. MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells. JNCI J. Natl. Cancer Inst. 105(16), 1172\u20131187. https:\/\/doi.org\/10.1093\/JNCI\/DJT184 (2013).","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"10","key":"4435_CR89","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/ni1516","volume":"8","author":"PE Jensen","year":"2007","unstructured":"Jensen, P. E. Recent advances in antigen processing and presentation. Nat. Immunol. 8(10), 1041\u20131048. https:\/\/doi.org\/10.1038\/ni1516 (2007).","journal-title":"Nat. Immunol."},{"issue":"7660","key":"4435_CR90","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/NATURE22815","volume":"546","author":"D Sulzer","year":"2017","unstructured":"Sulzer, D. et al. T cells of Parkinson\u2019s disease patients recognize \u03b1\u2013synuclein peptides. Nature 546(7660), 656. https:\/\/doi.org\/10.1038\/NATURE22815 (2017).","journal-title":"Nature"},{"issue":"11","key":"4435_CR91","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.12122\/J.ISSN.1673-4254.2021.11.07","volume":"41","author":"F Mu","year":"2021","unstructured":"Mu, F. et al. Regulatory mechanism of interferon regulatory factor 1 by \u03b1-synuclein in mouse Parkinson\u2019s disease model. Nan Fang Yi Ke Da Xue Xue Bao 41(11), 1641\u20131648. https:\/\/doi.org\/10.12122\/J.ISSN.1673-4254.2021.11.07 (2021).","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"1","key":"4435_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-26519-x","volume":"12","author":"S Bido","year":"2021","unstructured":"Bido, S. et al. Microglia-specific overexpression of \u03b1-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity. Nat. Commun. 12(1), 1\u201315. https:\/\/doi.org\/10.1038\/s41467-021-26519-x (2021).","journal-title":"Nat. Commun."},{"key":"4435_CR93","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/J.EXPNEUROL.2013.05.014","volume":"0","author":"CP Ramsey","year":"2014","unstructured":"Ramsey, C. P. & Tansey, M. G. A survey from 2012 of evidence for the role of neuroinflammation in neurotoxin animal models of Parkinson\u2019s Disease and potential molecular targets. Exp. Neurol. 0, 126. https:\/\/doi.org\/10.1016\/J.EXPNEUROL.2013.05.014 (2014).","journal-title":"Exp. Neurol."},{"issue":"4","key":"4435_CR94","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/S10863-016-9669-5\/FIGURES\/6","volume":"48","author":"CQ Dai","year":"2016","unstructured":"Dai, C. Q. et al. p53 and mitochondrial dysfunction: novel insight of neurodegenerative diseases. J. Bioenerg. Biomembr. 48(4), 337\u2013347. https:\/\/doi.org\/10.1007\/S10863-016-9669-5\/FIGURES\/6 (2016).","journal-title":"J. Bioenerg. Biomembr."},{"issue":"1","key":"4435_CR95","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/J.NEULET.2006.12.003","volume":"414","author":"M Mogi","year":"2007","unstructured":"Mogi, M., Kondo, T., Mizuno, Y. & Nagatsu, T. p53 protein, interferon-\u03b3, and NF-\u03baB levels are elevated in the parkinsonian brain. Neurosci. Lett. 414(1), 94\u201397. https:\/\/doi.org\/10.1016\/J.NEULET.2006.12.003 (2007).","journal-title":"Neurosci. Lett."},{"key":"4435_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/J.NEULET.2019.134641","volume":"716","author":"S Sekar","year":"2020","unstructured":"Sekar, S. & Taghibiglou, C. Nuclear accumulation of GAPDH, GluA2 and p53 in post-mortem substantia nigral region of patients with Parkinson\u2019s disease. Neurosci. Lett. 716, 134641. https:\/\/doi.org\/10.1016\/J.NEULET.2019.134641 (2020).","journal-title":"Neurosci. Lett."},{"issue":"17","key":"4435_CR97","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1101\/GAD.227249.113","volume":"27","author":"V Pant","year":"2013","unstructured":"Pant, V. et al. The p53\u2013Mdm2 feedback loop protects against DNA damage by inhibiting p53 activity but is dispensable for p53 stability, development, and longevity. Genes Dev. 27(17), 1857. https:\/\/doi.org\/10.1101\/GAD.227249.113 (2013).","journal-title":"Genes Dev."},{"issue":"20","key":"4435_CR98","doi-asserted-by":"publisher","first-page":"20702","DOI":"10.18632\/AGING.103998","volume":"12","author":"HY Chen","year":"2020","unstructured":"Chen, H. Y., Lin, C. H. & Teng, S. C. Stress-induced p53 drives BAG5 cochaperone expression to control \u03b1-synuclein aggregation in Parkinson\u2019s disease. Aging 12(20), 20702. https:\/\/doi.org\/10.18632\/AGING.103998 (2020).","journal-title":"Aging"},{"issue":"1","key":"4435_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13024-020-00364-W\/FIGURES\/9","volume":"15","author":"MR Karim","year":"2020","unstructured":"Karim, M. R. et al. \u03b1-Synucleinopathy associated c-Abl activation causes p53-dependent autophagy impairment. Mol. Neurodegener. 15(1), 1\u201318. https:\/\/doi.org\/10.1186\/S13024-020-00364-W\/FIGURES\/9 (2020).","journal-title":"Mol. Neurodegener."},{"issue":"52","key":"4435_CR100","doi-asserted-by":"publisher","first-page":"E8433","DOI":"10.1073\/PNAS.1612711114\/-\/DCSUPPLEMENTAL","volume":"113","author":"F Vogiatzi","year":"2016","unstructured":"Vogiatzi, F. et al. Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5. Proc. Natl. Acad. Sci. USA 113(52), E8433\u2013E8442. https:\/\/doi.org\/10.1073\/PNAS.1612711114\/-\/DCSUPPLEMENTAL (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"4435_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13046-023-02785-Z\/FIGURES\/8","volume":"42","author":"E Pavlakis","year":"2023","unstructured":"Pavlakis, E. et al. Mutant p53-ENTPD5 control of the calnexin\/calreticulin cycle: a druggable target for inhibiting integrin-\u03b15-driven metastasis. J. Exp. Clin. Cancer Res. 42(1), 1\u201321. https:\/\/doi.org\/10.1186\/S13046-023-02785-Z\/FIGURES\/8 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7","key":"4435_CR102","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/IJNP\/PYAD030","volume":"26","author":"H Li","year":"2023","unstructured":"Li, H., Zhang, Z., Li, H., Pan, X. & Wang, Y. New insights into the roles of p53 in central nervous system diseases. Int. J. Neuropsychopharmacol. 26(7), 465\u2013473. https:\/\/doi.org\/10.1093\/IJNP\/PYAD030 (2023).","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"4435_CR103","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/S13024-023-00699-0","volume":"19","author":"A Martirosyan","year":"2024","unstructured":"Martirosyan, A. et al. Unravelling cell type-specific responses to Parkinson\u2019s disease at single cell resolution. Mol. Neurodegener. 19(1), 7. https:\/\/doi.org\/10.1186\/S13024-023-00699-0 (2024).","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"4435_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/HMG\/DDAC161","volume":"32","author":"JD Prahl","year":"2022","unstructured":"Prahl, J. D., Pierce, S. E., Van Der Schans, E. J. C., Coetzee, G. A. & Tyson, T. The Parkinson\u2019s disease variant rs356182 regulates neuronal differentiation independently from alpha-synuclein. Hum. Mol. Genet. 32(1), 1. https:\/\/doi.org\/10.1093\/HMG\/DDAC161 (2022).","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"4435_CR105","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.14336\/AD.2023.0821-2","volume":"15","author":"X Jin","year":"2024","unstructured":"Jin, X. et al. Disruption of dopamine homeostasis associated with alteration of proteins in synaptic vesicles: A putative central mechanism of Parkinson\u2019s disease pathogenesis. Aging Dis. 15(3), 1204. https:\/\/doi.org\/10.14336\/AD.2023.0821-2 (2024).","journal-title":"Aging Dis."},{"key":"4435_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.108921","author":"A Booms","year":"2024","unstructured":"Booms, A., Pierce, S. E., van der Schans, E. J. C. & Coetzee, G. A. Parkinson\u2019s disease risk enhancers in microglia. iScience https:\/\/doi.org\/10.1016\/j.isci.2024.108921 (2024).","journal-title":"iScience"},{"issue":"11","key":"4435_CR107","doi-asserted-by":"publisher","first-page":"203","DOI":"10.31083\/J.JIN2311203\/8EF3A89DA1A723C7DED542079A3EA7A8.PDF","volume":"23","author":"O Harackiewicz","year":"2024","unstructured":"Harackiewicz, O. & Grembecka, B. The role of microglia and astrocytes in the pathomechanism of neuroinflammation in Parkinson\u2019s disease-focus on alpha-synuclein. J. Integr. Neurosci. 23(11), 203. https:\/\/doi.org\/10.31083\/J.JIN2311203\/8EF3A89DA1A723C7DED542079A3EA7A8.PDF (2024).","journal-title":"J. Integr. Neurosci."},{"issue":"23","key":"4435_CR108","doi-asserted-by":"publisher","first-page":"14753","DOI":"10.3390\/IJMS232314753","volume":"23","author":"S Yi","year":"2022","unstructured":"Yi, S., Wang, L., Wang, H., Ho, M. S. & Zhang, S. Pathogenesis of \u03b1-synuclein in Parkinson\u2019s disease: from a neuron-glia crosstalk perspective. Int. J. Mol. Sci. 23(23), 14753. https:\/\/doi.org\/10.3390\/IJMS232314753 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"4435_CR109","doi-asserted-by":"publisher","first-page":"20221051","DOI":"10.1515\/BIOL-2022-1051","volume":"20","author":"S Huang","year":"2025","unstructured":"Huang, S. et al. Neurodegenerative diseases and neuroinflammation-induced apoptosis. Open Life Sci. 20(1), 20221051. https:\/\/doi.org\/10.1515\/BIOL-2022-1051 (2025).","journal-title":"Open Life Sci."},{"issue":"1","key":"4435_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01353-3","volume":"8","author":"X Dong-Chen","year":"2023","unstructured":"Dong-Chen, X., Yong, C., Yang, X., Chen-Yu, S. T. & Li-Hua, P. Signaling pathways in Parkinson\u2019s disease: Molecular mechanisms and therapeutic interventions. Signal Transduct. Target. Ther. 8(1), 1\u201318. https:\/\/doi.org\/10.1038\/s41392-023-01353-3 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"4435_CR111","doi-asserted-by":"publisher","first-page":"209.e1","DOI":"10.1016\/J.NEUROBIOLAGING.2015.09.014","volume":"37","author":"AA Davis","year":"2016","unstructured":"Davis, A. A. et al. Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression. Neurobiol. Aging 37, 209.e1-209.e7. https:\/\/doi.org\/10.1016\/J.NEUROBIOLAGING.2015.09.014 (2016).","journal-title":"Neurobiol. Aging"},{"issue":"9","key":"4435_CR112","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/ng.642","volume":"42","author":"TH Hamza","year":"2010","unstructured":"Hamza, T. H. et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson\u2019s disease. Nat. Genet. 42(9), 781\u2013785. https:\/\/doi.org\/10.1038\/ng.642 (2010).","journal-title":"Nat. Genet."},{"issue":"6099","key":"4435_CR113","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1126\/SCIENCE.1222794\/SUPPL_FILE\/MAURANO.SM.PDF","volume":"337","author":"MT Maurano","year":"2012","unstructured":"Maurano, M. T. et al. Systematic localization of common disease-associated variation in regulatory DNA. Science (1979) 337(6099), 1190\u20131195. https:\/\/doi.org\/10.1126\/SCIENCE.1222794\/SUPPL_FILE\/MAURANO.SM.PDF (2012).","journal-title":"Science (1979)"},{"issue":"6469","key":"4435_CR114","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1126\/SCIENCE.AAY0793\/SUPPL_FILE\/AAY0793-NOTT-TABLE-S8.XLSX","volume":"366","author":"A Nott","year":"2019","unstructured":"Nott, A. et al. Brain cell type\u2013specific enhancer\u2013promoter interactome maps and disease-risk association. Science (1979) 366(6469), 1134\u20131139. https:\/\/doi.org\/10.1126\/SCIENCE.AAY0793\/SUPPL_FILE\/AAY0793-NOTT-TABLE-S8.XLSX (2019).","journal-title":"Science (1979)"},{"issue":"1","key":"4435_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13059-023-03123-4","volume":"24","author":"SK Maden","year":"2023","unstructured":"Maden, S. K. et al. Challenges and opportunities to computationally deconvolve heterogeneous tissue with varying cell sizes using single-cell RNA-sequencing datasets. Genome Biol. 24(1), 1\u201326. https:\/\/doi.org\/10.1186\/S13059-023-03123-4 (2023).","journal-title":"Genome Biol."},{"key":"4435_CR116","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0505-24.2025","author":"KC Olney","year":"2025","unstructured":"Olney, K. C. et al. Postmortem interval leads to loss of disease-specific signatures in brain tissue. eNeuro https:\/\/doi.org\/10.1523\/ENEURO.0505-24.2025 (2025).","journal-title":"eNeuro"},{"issue":"7675","key":"4435_CR117","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nature24277","volume":"550","author":"F Aguet","year":"2017","unstructured":"Aguet, F. et al. Genetic effects on gene expression across human tissues. Nature 550(7675), 204\u2013213 (2017).","journal-title":"Nature"},{"issue":"1","key":"4435_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13024-021-00450-7\/METRICS","volume":"16","author":"L Toker","year":"2021","unstructured":"Toker, L. et al. Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson\u2019s disease brain. Mol. Neurodegener. 16(1), 1\u201320. https:\/\/doi.org\/10.1186\/S13024-021-00450-7\/METRICS (2021).","journal-title":"Mol. Neurodegener."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04435-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04435-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04435-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:46:56Z","timestamp":1751431616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04435-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":118,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4435"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-04435-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23358"}}